相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Parallel Reaction Monitoring-Parallel Accumulation-Serial Fragmentation (prm-PASEF) Approach for Multiplexed Absolute Quantitation of Proteins in Human Plasma
Alexander Brzhozovskiy et al.
ANALYTICAL CHEMISTRY (2022)
Cerebrospinal Fluid Levels of Prodynorphin-Derived Peptides Are Decreased in Huntington's Disease
M. H. D. Rami Al Shweiki et al.
MOVEMENT DISORDERS (2021)
Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
Valter Niemela et al.
MOVEMENT DISORDERS (2021)
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease
Zhen-Yi Andy Ou et al.
SCIENTIFIC REPORTS (2021)
Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies
Aidong Yuan et al.
FRONTIERS IN NEUROSCIENCE (2021)
Plasma neurofilament light in Huntington's disease: A marker for disease onset, but not symptom progression
Georgia M. Parkin et al.
PARKINSONISM & RELATED DISORDERS (2021)
Benchmarking the Orbitrap Tribrid Eclipse for Next Generation Multiplexed Proteomics
Qing Yu et al.
ANALYTICAL CHEMISTRY (2020)
Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregates
Paula Garcia-Huerta et al.
ACTA NEUROPATHOLOGICA (2020)
Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease
Alexander J. Lowe et al.
PLOS ONE (2020)
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease
Filipe B. Rodrigues et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Determination of the concentration range for 267 proteins from 21 lots of commercial human plasma using highly multiplexed multiple reaction monitoring mass spectrometry
Claudia Gaither et al.
ANALYST (2020)
Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease
Galen E. B. Wright et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J. Tabrizi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
Uku Raudvere et al.
NUCLEIC ACIDS RESEARCH (2019)
A sensitive and simple targeted proteomics approach to quantify transcription factor and membrane proteins of the unfolded protein response pathway in glioblastoma cells
Chi D. L. Nguyen et al.
SCIENTIFIC REPORTS (2019)
CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset
Jong-Min Lee et al.
CELL (2019)
Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System
Sarah M. Carpanini et al.
FRONTIERS IN IMMUNOLOGY (2019)
Neurofilament light protein in blood predicts regional atrophy in Huntington disease
Eileanoir B. Johnson et al.
NEUROLOGY (2018)
Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease
Valter Niemela et al.
PLOS ONE (2018)
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease
Lauren M. Byrne et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward
Edina Silajdzic et al.
JOURNAL OF HUNTINGTONS DISEASE (2018)
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
Lauren M. Byrne et al.
LANCET NEUROLOGY (2017)
High Sensitivity Quantitative Proteomics Using Automated Multidimensional Nano-flow Chromatography and Accumulated Ion Monitoring on Quadrupole-Orbitrap-Linear Ion Trap Mass Spectrometer
Paolo Cifani et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
Motor, cognitive, and functional declines contribute to a single progressive factor in early HD
Scott A. Schobel et al.
NEUROLOGY (2017)
CombiROC: an interactive web tool for selecting accurate marker combinations of omics data
Saveria Mazzara et al.
SCIENTIFIC REPORTS (2017)
mixOmics: An R package for 'omics feature selection and multiple data integration
Florian Rohart et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease
Alba Di Pardo et al.
SCIENTIFIC REPORTS (2017)
Validation of Ultrasensitive Mutant Huntingtin Detection in Human Cerebrospinal Fluid by Single Molecule Counting Immunoassay
Valentina Fodale et al.
JOURNAL OF HUNTINGTONS DISEASE (2017)
Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease
Filipe Brogueira Rodrigues et al.
PLOS ONE (2016)
Cerebrospinal Fluid Biomarkers for Huntington's Disease
Lauren M. Byrne et al.
JOURNAL OF HUNTINGTONS DISEASE (2016)
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease
Tua Vinther-Jensen et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology
Janelle Drouin-Ouellet et al.
ANNALS OF NEUROLOGY (2015)
Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease
Jong-Min Lee et al.
CELL (2015)
Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease
T. Vinther-Jensen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients
Edward J. Wild et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression
Amber L. Southwell et al.
SCIENTIFIC REPORTS (2015)
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease
Daniel Aberg et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A. Ross et al.
NATURE REVIEWS NEUROLOGY (2014)
Neurovascular abnormalities in humans and mice with Huntington's disease
Chien-Yuan Lin et al.
EXPERIMENTAL NEUROLOGY (2013)
Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease
Gelareh Mazarei et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
Sarah J. Tabrizi et al.
LANCET NEUROLOGY (2013)
Multiplexed Evaluation of Serum and CSF Pharmacokinetics of Brain-Targeting Single-Domain Antibodies Using a NanoLC-SRM-ILIS Method
Arsalan S. Haqqani et al.
MOLECULAR PHARMACEUTICS (2013)
IκB Kinase/Nuclear Factor κB-Dependent Insulin-Like Growth Factor 2 (Igf2) Expression Regulates Synapse Formation and Spine Maturation via Igf2 Receptor Signaling
Michael J. Schmeisser et al.
JOURNAL OF NEUROSCIENCE (2012)
Gene Expression Profiling of Neural Stem Cells and Their Neuronal Progeny Reveals IGF2 as a Regulator of Adult Hippocampal Neurogenesis
Oliver Bracko et al.
JOURNAL OF NEUROSCIENCE (2012)
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
Sarah J. Tabrizi et al.
LANCET NEUROLOGY (2012)
Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum
Tujin Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
Sarah Jesse et al.
JOURNAL OF NEUROLOGY (2011)
Reduction of mutant huntingtin accumulation and toxicity by lysosomal cathepsins D and B in neurons
Qiuli Liang et al.
MOLECULAR NEURODEGENERATION (2011)
A critical role for IGF-II in memory consolidation and enhancement
Dillon Y. Chen et al.
NATURE (2011)
Worsening of Huntington disease phenotype in CB1 receptor knockout mice
Stephane Mievis et al.
NEUROBIOLOGY OF DISEASE (2011)
Increased Prothrombin, Apolipoprotein A-IV, and Haptoglobin in the Cerebrospinal Fluid of Patients with Huntington's Disease
Yen-Chu Huang et al.
PLOS ONE (2011)
Expression analysis of novel striatal-enriched genes in Huntington disease
Gelareh Mazarei et al.
HUMAN MOLECULAR GENETICS (2010)
Brain-specific Proteins Decline in the Cerebrospinal Fluid of Humans with Huntington Disease
Qiaojun Fang et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease
Radu Constantinescu et al.
PARKINSONISM & RELATED DISORDERS (2009)
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates
Annette Dalrymple et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Regional and cellular gene expression changes in human Huntington's disease brain
A Hodges et al.
HUMAN MOLECULAR GENETICS (2006)
A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length
DR Langbehn et al.
CLINICAL GENETICS (2004)
Persistent increase in olfactory type G-protein α subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease
JC Corvol et al.
JOURNAL OF NEUROSCIENCE (2004)
Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study
YP Deng et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2004)
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
C Zuccato et al.
SCIENCE (2001)
Brain-derived neurotrophic factor in Huntington disease
I Ferrer et al.
BRAIN RESEARCH (2000)
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
R Luthi-Carter et al.
HUMAN MOLECULAR GENETICS (2000)
The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease
M Glass et al.
NEUROSCIENCE (2000)
分享论文
